|
1
|
Greco A, Rizzo MI, De Virgilio A, Gallo A,
Fusconi M, Pagliuca G, Martellucci S, Turchetta R and De Vincentiis
M: Cancer stem cells in laryngeal cancer: What we know. Eur Arch
Otorhinolaryngol. 273:3487–3495. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yu D, Liu Y, Yang J, Jin C, Zhao X, Cheng
J, Liu X and Qi X: Clinical implications of BMI-1 in cancer stem
cells of laryngeal carcinoma. Cell Biochem Biophys. 71:261–269.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mäkitie AA and Monni O: Molecular
profiling of laryngeal cancer. Expert Rev Anticancer Ther.
9:1251–1260. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wan G, Zhou L, Xie M, Chen H and Tian J:
Characterization of side population cells from laryngeal cancer
cell lines. Head Neck. 32:1302–1309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
De Virgilio A, Ralli M, Longo L, Mancini
P, Attanasio G, Atturo F, De Vincentiis M and Greco A:
Electrochemotherapy in head and neck cancer: A review of an
emerging cancer treatment. Oncol Lett. 16:3415–3423.
2018.PubMed/NCBI
|
|
7
|
Bussu F, Paludetti G, Almadori G, De
Virgilio A, Galli J, Miccichè F, Tombolini M, Rizzo D, Gallo A,
Giglia V, et al: Comparison of total laryngectomy with surgical
(cricohyoidopexy) and nonsurgical organ-preservation modalities in
advanced laryngeal squamous cell carcinomas: A multicenter
retrospective analysis. Head Neck. 35:554–561. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
García SA, Weitz J and Schölch S:
Circulating tumor cells. Methods Mol Biol. 1692:213–219. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu XL, Tu Q, Faure G, Gallet P, Kohler C
and Bittencourt MC: Diagnostic and prognostic value of circulating
tumor cells in head and neck squamous cell carcinoma: A systematic
review and meta-analysis. Sci Rep. 6:202102016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Z, Cui K, Xue Y, Tong F and Li S:
Prognostic value of circulating tumor cells in patients with
squamous cell carcinoma of the head and neck: A systematic review
and meta-analysis. Med Oncol. 32:1642015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Grisanti S, Almici C, Consoli F, Buglione
M, Verardi R, Bolzoni-Villaret A, Bianchetti A, Ciccarese C,
Mangoni M, Ferrari L, et al: Circulating tumor cells in patients
with recurrent or metastatic head and neck carcinoma: Prognostic
and predictive significance. PLoS One. 9:e1039182014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Alix-Panabieres C and Pantel K: The
circulating tumor cells: Liquid biopsy of cancer. Klin Lab Diagn.
4:60–64. 2014.(In Russian).
|
|
13
|
Heitzer E, Auer M, Ulz P, Geigl JB and
Speicher MR: Circulating tumor cells and DNA as liquid biopsies.
Genome Med. 5:732013. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hristozova T, Konschak R, Stromberger C,
Fusi A, Liu Z, Weichert W, Stenzinger A, Budach V, Keilholz U and
Tinhofer I: The presence of circulating tumor cells (CTCs)
correlates with lymph node metastasis in nonresectable squamous
cell carcinoma of the head and neck region (SCCHN). Ann Oncol.
22:1878–1885. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cohen SJ, Punt CJ, Iannotti N, Saidman BH,
Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, et
al: Relationship of circulating tumor cells to tumor response,
progression-free survival, and overall survival in patients with
metastatic colorectal cancer. J Clin Oncol. 26:3213–3221. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Danila DC, Heller G, Gignac GA,
Gonzalez-Espinoza R, Anand A, Tanaka E, Lilja H, Schwartz L, Larson
S, Fleisher M, et al: Circulating tumor cell number and prognosis
in progressive castration-resistant prostate cancer. Clin Cancer
Res. 13:7053–7058. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cristofanilli M, Hayes DF, Budd GT, Ellis
MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC,
et al: Circulating tumor cells: A novel prognostic factor for newly
diagnosed metastatic breast cancer. J Clin Oncol. 23:1420–1430.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nonaka T and Wong DT: Liquid biopsy in
head and neck cancer: Promises and Challenges. J Dent Res.
97:701–708. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Economopoulou P, Kotsantis I, Kyrodimos E,
Lianidou ES and Psyrri A: Liquid biopsy: An emerging prognostic and
predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC).
Focus on Circulating Tumor Cells (CTCs). Oral Oncol. 74:83–89.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao S, Liu Y, Zhang Q, Li H, Zhang M, Ma
W, Zhao W, Wang J and Yang M: The prognostic role of circulating
tumor cells (CTCs) detected by RT-PCR in breast cancer: A
meta-analysis of published literature. Breast Cancer Res Treat.
130:809–816. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rahbari NN, Aigner M, Thorlund K, Mollberg
N, Motschall E, Jensen K, Diener MK, Büchler MW, Koch M and Weitz
J: Meta-analysis shows that detection of circulating tumor cells
indicates poor prognosis in patients with colorectal cancer.
Gastroenterology. 138:1714–1726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Parkinson DR, Dracopoli N, Petty BG,
Compton C, Cristofanilli M, Deisseroth A, Hayes DF, Kapke G, Kumar
P, Lee JS, et al: Considerations in the development of circulating
tumor cell technology for clinical use. J Transl Med. 10:1382012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ferreira MM, Ramani VC and Jeffrey SS:
Circulating tumor cell technologies. Mol Oncol. 10:374–394. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
El-Heliebi A, Kroneis T, Zöhrer E,
Haybaeck J, Fischereder K, Kampel-Kettner K, Zigeuner R, Pock H,
Riedl R, Stauber R, et al: Are morphological criteria sufficient
for the identification of circulating tumor cells in renal cancer?
J Transl Med. 11:2142013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Papadaki MA, Stoupis G, Theodoropoulos PA,
Mavroudis D, Georgoulias V and Agelaki S: Circulating tumor cells
with stemness and epithelial-to-mesenchymal transition features are
chemoresistant and predictive of poor outcome in metastatic breast
cancer. Mol Cancer Ther. 18:437–447. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Joosse SA and Pantel K: Biologic
challenges in the detection of circulating tumor cells. Cancer Res.
73:8–11. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Krebs MG, Hou JM, Sloane R, Lancashire L,
Priest L, Nonaka D, Ward TH, Backen A, Clack G, Hughes A, et al:
Analysis of circulating tumor cells in patients with non-small cell
lung cancer using epithelial marker-dependent and -independent
approaches. J Thorac Oncol. 7:306–315. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Christiansen JJ and Rajasekaran AK:
Reassessing epithelial to mesenchymal transition as a prerequisite
for carcinoma invasion and metastasis. Cancer Res. 66:8319–8326.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Desitter I, Guerrouahen BS, Benali-Furet
N, Wechsler J, Jänne PA, Kuang Y, Yanagita M, Wang L, Berkowitz JA,
Distel RJ, et al: A new device for rapid isolation by size and
characterization of rare circulating tumor cells. Anticancer Res.
31:427–441. 2011.PubMed/NCBI
|
|
30
|
Zheng S, Lin HK, Lu B, Williams A, Datar
R, Cote RJ and Tai YC: 3D microfilter device for viable circulating
tumor cell (CTC) enrichment from blood. Biomed Microdevices.
13:203–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vona G, Sabile A, Louha M, Sitruk V,
Romana S, Schütze K, Capron F, Franco D, Pazzagli M, Vekemans M, et
al: Isolation by size of epithelial tumor cells : A new method for
the immunomorphological and molecular characterization of
circulating tumor cells. Am J Pathol. 156:57–63. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang SH and O'Sullivan B: Overview of the
8th edition TNM classification for head and neck cancer. Curr Treat
Options Oncol. 18:402017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nicolazzo C, Raimondi C, Francescangeli F,
Ceccarelli S, Trenta P, Magri V, Marchese C, Zeuner A, Gradilone A
and Gazzaniga P: EpCAM-expressing circulating tumor cells in
colorectal cancer. Int J Biol Markers. 32:e415–e420. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yu D, Jin C, Liu Y, Yang J, Zhao Y, Wang
H, Zhao X, Cheng J, Liu X and Liu C: Clinical implications of
cancer stem cell-like side population cells in human laryngeal
cancer. Tumour Biol. 34:3603–3610. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang L, Lang JC, Balasubramanian P, Jatana
KR, Schuller D, Agrawal A, Zborowski M and Chalmers JJ:
Optimization of an enrichment process for circulating tumor cells
from the blood of head and neck cancer patients through depletion
of normal cells. Biotechnol Bioeng. 102:521–534. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang HD, Gong SC, Liu YQ, Liang LJ, He
SB, Zhang QX, Si MY and Yu ZK: The significance of circulating
tumor cells in head and neck squamous cell carcinoma: A preliminary
study. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 53:39–44.
2018.PubMed/NCBI
|
|
37
|
Chudasama D, Katopodis P, Stone N, Haskell
J, Sheridan H, Gardner B, Urnovitz H, Schuetz E, Beck J, Hall M, et
al: Liquid biopsies in lung cancer: Four emerging technologies and
potential clinical applications. Cancers (Basel). 11:E3312019.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chudasama D, Burnside N, Beeson J,
Karteris E, Rice A and Anikin V: Perioperative detection of
circulating tumour cells in patients with lung cancer. Oncol Lett.
14:1281–1286. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Amantini C, Morelli MB, Nabissi M, Piva F,
Marinelli O, Maggi F, Bianchi F, Bittoni A, Berardi R, Giampieri R,
et al: Expression profiling of circulating tumor cells in
pancreatic ductal adenocarcinoma patients: Biomarkers predicting
overall survival. Front Oncol. 9:8742019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nicolazzo C, Raimondi C, Gradilone A,
Emiliani A, Zeuner A, Francescangeli F, Belardinilli F, Seminara P,
Loreni F and Magri V: Circulating tumor cells in right- and
left-sided colorectal cancer. Cancers (Basel). 11:E10422019.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kuvendjiska J, Bronsert P, Martini V, Lang
S, Pitman MB, Hoeppner J, Kulemann B, et al: Non-metastatic
esophageal adenocarcinoma: Circulating tumor cells in the course of
multimodal tumor treatment. Cancers (Basel). 11:E3972019.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nicolazzo C, Colangelo L, Corsi A, Carpino
G, Gradilone A, Sonato C, Raimondi C, Gaudio E, Gazzaniga P and
Gianni W: Liquid Biopsy in Rare Cancers: Lessons from
Hemangiopericytoma. Anal Cell Pathol (Amst).
2018:97185852018.PubMed/NCBI
|
|
43
|
Mascalchi M, Maddau C, Sali L, Bertelli E,
Salvianti F, Zuccherelli S, Matucci M, Borgheresi A, Raspanti C,
Lanzetta M, et al: Circulating tumor cells and microemboli can
differentiate malignant and benign pulmonary lesions. J Cancer.
8:2223–2230. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fina E, Necchi A, Bottelli S, Reduzzi C,
Pizzamiglio S, Iacona C, Daidone MG, Verderio P and Cappelletti V:
Detection of circulating tumour cells in urothelial cancers and
clinical correlations: Comparison of two methods. Dis Markers.
2017:34149102017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Awe JA, Saranchuk J, Drachenberg D and Mai
S: Filtration-based enrichment of circulating tumor cells from all
prostate cancer risk groups. Urol Oncol. 35:300–309. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mu Z, Benali-Furet N, Uzan G, Znaty A, Ye
Z, Paolillo C, Wang C, Austin L, Rossi G, Fortina P, Yang H, et al:
Detection and characterization of circulating tumor associated
cells in metastatic Breast Cancer. Int J Mol Sci. 17:E16652016.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kulasinghe A, Kenny L, Perry C, Thiery JP,
Jovanovic L, Vela I, Nelson C and Punyadeera C: Impact of
label-free technologies in head and neck cancer circulating tumour
cells. Oncotarget. 7:71223–71234. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hashimoto M, Tanaka F, Yoneda K, Takuwa T,
Matsumoto S, Okumura Y, Kondo N, Tsubota N, Tsujimura T, Tabata C,
et al: Significant increase in circulating tumour cells in
pulmonary venous blood during surgical manipulation in patients
with primary lung cancer. Interact Cardiovasc Thorac Surg.
18:775–783. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hou JM, Greystoke A, Lancashire L,
Cummings J, Ward T, Board R, Amir E, Hughes S, Krebs M, Hughes A,
et al: Evaluation of circulating tumor cells and serological cell
death biomarkers in small cell lung cancer patients undergoing
chemotherapy. Am J Pathol. 175:808–816. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang HM, Wu MH, Chang PH, Lin HC, Liao CD,
Wu SM, Hung TM, Lin CY, Chang TC, Tzu-Tsen Y, et al: The change in
circulating tumor cells before and during concurrent
chemoradiotherapy is associated with survival in patients with
locally advanced head and neck cancer. Head Neck. 41:2676–2687.
2019.PubMed/NCBI
|
|
51
|
Chikamatsu K, Tada H, Takahashi H,
Kuwabara-Yokobori Y, Ishii H, Ida S and Shino M: Expression of
immune-regulatory molecules in circulating tumor cells derived from
patients with head and neck squamous cell carcinoma. Oral Oncol.
89:34–39. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kulasinghe A, Kapeleris J, Kimberley R,
Mattarollo SR, Thompson EW, Thiery JP, Kenny L, O'Byrne K and
Punyadeera C: The prognostic significance of circulating tumor
cells in head and neck and non-small-cell lung cancer. Cancer Med.
7:5910–5919. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ng SP, Bahig H, Wang J, Cardenas CE, Lucci
A, Hall CS, Meas S, Sarli VN, Yuan Y, Urbauer DL, et al: Predicting
treatment Response based on Dual assessment of magnetic resonance
Imaging kinetics and Circulating Tumor cells in patients with Head
and Neck cancer (PREDICT-HN): Matching ‘liquid biopsy’ and
quantitative tumor modeling. BMC Cancer. 18:9032018. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Morgan TM, Wang X, Qian X, Switchenko JM,
Nie S, Patel KR, Cassidy RJ, Shin DM and Beitler JJ: Measurement of
circulating tumor cells in squamous cell carcinoma of the head and
neck and patient outcomes. Clin Transl Oncol. 21:342–347. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lou JL, Guo L, Zheng WH, Zhao JZ, Zhao JQ,
Liang Z, Wang SY and Fang MY: Peripheral blood circulating tumor
cells in local advanced head and neck squamous cell carcinoma.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 52:824–829. 2017.(In
Chinese). PubMed/NCBI
|
|
56
|
Kawada T, Takahashi H, Sakakura K, Ida S,
Mito I, Toyoda M and Chikamatsu K: Circulating tumor cells in
patients with head and neck squamous cell carcinoma: Feasibility of
detection and quantitation. Head Neck. 39:2180–2186. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Fanelli MF, Oliveira TB, Braun AC, Corassa
M, Abdallah EA, Nicolau UR, da Silva Alves V, Garcia D, Calsavara
VF, Kowalski LP, et al: Evaluation of incidence, significance, and
prognostic role of circulating tumor microemboli and transforming
growth factor-β receptor I in head and neck cancer. Head Neck.
39:2283–2292. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
He S, Li P, He S, Long T, Zhang N, Fang J
and Yu Z: Detection of circulating tumour cells with the CellSearch
system in patients with advanced-stage head and neck cancer:
Preliminary results. J Laryngol Otol. 127:788–793. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Nichols AC, Lowes LE, Szeto CC, Basmaji J,
Dhaliwal S, Chapeskie C, Todorovic B, Read N, Venkatesan V, Hammond
A, et al: Detection of circulating tumor cells in advanced head and
neck cancer using the CellSearch system. Head Neck. 34:1440–1444.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Winter SC, Stephenson SA, Subramaniam SK,
Paleri V, Ha K, Marnane C, Krishnan S and Rees G: Long term
survival following the detection of circulating tumour cells in
head and neck squamous cell carcinoma. BMC Cancer. 9:4242009.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Sun T, Zou K, Yuan Z, Yang C, Lin X and
Xiong B: Clinicopathological and prognostic significance of
circulating tumor cells in patients with head and neck cancer: A
meta-analysis. OncoTargets Ther. 10:3907–3916. 2017. View Article : Google Scholar
|
